Granted Patent
B2
US 11,512,079 · App. 16/770,476 · Granted Nov 29, 2022
Heterocycle substituted pyridine derivative antifungal agents
Inventors:
Michael Trzoss (San Diego, CA); Jonathan Covel (San Diego, CA); Karen Joy Shaw (San Diego, CA); Peter Webb (San Diego, CA)
Assignee:
Amplyx Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Described herein are heterocycle substituted pyridine derivative antifungal agents and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of fungal diseases and infections.
Claims (4)
1. The compound
or pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition, comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient.
3. A method of treating a fungal disease in a subject in need thereof, comprising administering to a subject a therapeutically effective amount of a compound of claim 1 , or pharmaceutically acceptable salt thereof.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 12, 2023
From: AMPLYX PHARMACEUTICALS, INC.
To: BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL
Reel/Frame 065843/0001 →
ASSIGNEE ADDRESS CORRECTION
Recorded Mar 10, 2023
From: AMPLYX PHARMACEUTICALS, INC.
To: AMPLYX PHARMACEUTICALS, INC.
Reel/Frame 063025/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 8, 2020
From: TRZOSS, MICHAEL; COVEL, JONATHAN; SHAW, KAREN JOY; WEBB, PETER
To: AMPLYX PHARMACEUTICALS, INC.
Reel/Frame 052869/0700 →
Continuity (3)
Provisional Application
62649225
· Mar 28, 2018
Provisional Application
62595894
· Dec 7, 2017
Cited By (1)